Pharmaceutical and Healthcare Labelling

In the wide variety of pharmaceutical labelling applications, labels may be required to have special properties such as:

  • an adhesive with non-migration properties when labelling on a liquid filled LDEP package.
  • tolerance of various sterilisation processes or storage at -80 °C.
  • face materials that are thermal transfer printable.

Labelling small-diameter substrates


On small-diameter substrates, such as test tubes, syringes and vials, labelling requires special attention, especially when the diameter is below 15 mm.

Performance-wise, labelling glass test tubes differs significantly from labelling polyethylene (PE) or polypropylene (PP) test tubes. Overlapped labelling helps assure success, together with an appropriate combination of face material and adhesive.

The importance of traceability


Pharmaceutical products need to be traceable, and pharmaceutical packages usually have batch numbers and expiry dates printed on the label. Accordingly, the printability of the face material, often by thermal transfer, is important.

UPM Raflatac provides certificated products
 

Pharmaceutical companies require that printers and converters use special label materials that have been put through extensive assessments such as migration studies and stability tests. Pharmaceutical companies are served directly by UPM Raflatac with technical support for migration studies. After signing an NDA, a full set of documents will be available and chemical details may be communicated.

UPM Raflatac product chart for Pharmaceutical labelling



Safety requirements and certificates


Labelling pharmaceutical products requires specialist face materials and adhesives that meet the requirements of the industry.

UPM Raflatac has a range of suitable products:
Pharmaceutical labelling booklet – Safety first (PDF)

Self-adhesive laminates manufactured by UPM Raflatac are safe products in accordance with the material description given by EC Directive 2001/95/EC, Article 2(b).

Material safety data sheets as referred to in Directive 1999/45/EC, Article 14 and Directive 2001/58/EC are not applicable to self-adhesive materials.

The presence of heavy metals is a concern in many applications, including pharmaceutical. UPM Raflatac's products comply with legislation regarding the presence of heavy metals.

* Health and safety
Statement regarding the Health and Safety of UPM Raflatac's products

* Heavy metals
Certificate of conformance for levels of heavy metals in UPM Raflatac products